Photodynamic therapy and cancer: a brief sightseeing tour

Bibliography

• VON TAPPEINER HVH: Die photodynamische Erscheinung (Sensibilisierung durch fluoreszierende Stoffe). Monatsschrift Kinderheilkunde, (1909) 8:698-741.
   Google Scholar
• LIPSON RL, BALDES EJ: The photodynamic properties of a particular hematoporphyrin derivative. Arch. Dermatol. (1960) 82:508-516.
   PubMed Web of Science ®Google Scholar
• LIPSON RL, BALDES EJ, OLSEN AM: Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J. Thorac. Cardiovasc. Surg. (1961) 42:623-629
   PubMed Web of Science ®Google Scholar
• MOAN J, BERG K: The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. (1991) 53:549-553
   PubMed Web of Science ®Google Scholar
• KORBELIK M, KROSL G: Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer. (1996) 73:506-513.
   PubMed Web of Science ®Google Scholar
• BUGELSKI PJ, PORTER CW, DOUGHERTY TJ: Autoradiographic distribution of hematoporphyrin derivative in normal and tumour tissue of the mouse. Cancer Res. (1981) 41:4606-4612.
   PubMed Web of Science ®Google Scholar
• PENG Q, MOAN J, FARRANTS G, DANIELSEN HE, RIMINGTON C: Localization of potent photosensitisers in human tumour LOX by means of laser scanning microscopy. Cancer Lett. (1991) 58:17-27.
   PubMed Web of Science ®Google Scholar
• HENDERSON BW, FINGAR VH: Oxygen limitation of direct tumour cell kill during photodynamic treatment of a murine tumour model. Photochem. Photobiol. (1989) 49:299-304.
   PubMed Web of Science ®Google Scholar
• WIEMAN TJ, MANG TS, FINGAR VH et al.: Effect of photodynamic therapy on blood flow in normal and tumour vessels. Surgery (1988) 104:512-517.
   PubMed Web of Science ®Google Scholar
• STAR WM, MARIJNISSEN HP, VAN DEN BERG-BLOK AE, VERSTEEG JA et al.: Destruction of rat mammary tumour and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. (1986) 46:2532-2540.
   PubMed Web of Science ®Google Scholar
• DOLMANS DE, KADAMBI A, HILL JS, WATERS CA et al.: Vascular accumulation of a novel photosensitiser, MV6401, causes selective thrombosis in tumour vessels after photodynamic therapy. Cancer Res. (2002) 62:2151-2156.
   PubMed Web of Science ®Google Scholar
• GOLLNICK SO, EVANS SS, BAUMANN H et al.: Role of cytokines in photodynamic therapy-induced local and systemic inflammation.Br. J. Cancer (2003) 88:1772-1779.
   PubMed Web of Science ®Google Scholar
• GOLLNICK SO, VAUGHAN L, HENDERSON BW: Generation of effective antitumour vaccines using photodynamic therapy. Cancer Res. (2002) 62:1604-1608.
   PubMed Web of Science ®Google Scholar
• BRANCALEONI L, MOSELEY H: "Laser and non-laser light sources for photodynamic therapy" Lasers Med. Sci. (2002) 17:173-186.
   PubMed Web of Science ®Google Scholar
• RIPLEY PM, MILLS TN, BROOKES JAS: Measurements of the emission profiles of cylindrical light diffusers using a video technique. Lasers Med. Sci. (1999) 14:67-72.
   PubMed Web of Science ®Google Scholar
• MURRER LHP , MARIJNISSEN JPA, STAR WM: Improvements in the design of linear diffusers for photodynamic therapy. Phys. Med. Biol. (1997) 42:1461-1464.
   PubMed Web of Science ®Google Scholar
• SVAASAND LO, ELLINGSEN R: Optical properties of human brain. Photochem. Photobiol. (1983) 38:293-299.
   PubMed Web of Science ®Google Scholar
• ZHU TC, FINLAY JC, HAHN SM: Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during Motexafin lutetium-mediated photodynamic therapy. J. Photochem. Photobiol. B. (2005) 79:231-241.
   PubMed Web of Science ®Google Scholar
• PANJEHPOUR M, OVERHOLT BF, PHAN MN, HAYDEK JM: Optimization of light dosimetry for photodynamic therapy of Barrett's oesophagus: efficacy vs. incidence of stricture after treatment. Gastrointest. Endosc. (2005) 61:13-18.
   PubMed Web of Science ®Google Scholar
• ZHU TC, DIMOFTE A, FINLAY JC et al.: Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem. Photobiol. (2005) 81:96-105.
   PubMed Web of Science ®Google Scholar
• JACQUES SL: Light distributions from point, line and plane sources for photochemical Id fluorescence in turbid biological tissues. Photochem. Photobiol. (1998) 67:23-32.
   PubMed Web of Science ®Google Scholar
• HUANG Z: A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. (2005) 4:283-293.
   PubMed Web of Science ®Google Scholar
• BROWN SB, BROWN EA, WALKER I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. (2004) 5:497-508.
   PubMed Web of Science ®Google Scholar
• HOPPER C: Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. (2000) 1:212-219.
   PubMedGoogle Scholar
• SHARMAN WM, ALLEN CM, VAN LIER JE: Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today (1999) 4:507-517.
   PubMed Web of Science ®Google Scholar
• CHAN AL, JUAREZ M, ALLEN R, VOLZ W, ALBERTSON T: Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatol. Photoimmunol. Photomed. (2005) 21:72-78.
   PubMed Web of Science ®Google Scholar
• WONG TW, AIZAWA K, SHEYHEDIN I, WUSHUR C, KATO H: Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. J. Pharmacol. Sci. (2003) 93:136-142.
   PubMed Web of Science ®Google Scholar
• KATO H, FURUKAWA K, SATO M et al.: Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorine6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer (2003) 42:103-111.
   PubMed Web of Science ®Google Scholar
• LIM JI: Photodynamic therapy for choroidal neovascular disease: photosensitisers and clinical trials. Ophthalmol. Clin. North Am. (2002) 15:473-478.
   Google Scholar
• TABER SW, FINGAR VH, COOTS CT, WIEMAN TJ: Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Clin. Cancer Res. (1998) 4:2741-2746.
   PubMed Web of Science ®Google Scholar
• VAN DUIJNHOVEN FH, ROVERS JP, ENGELMANN K et al.: Photodynamic therapy with 5,10,15,20-tetrakis(m-hydroxyphenyl) bacteriochlorin for colorectal liver metastases is safe and feasible: results from a phase I study. Ann. Surg. Oncol. (2005) 12:808-816.
   PubMed Web of Science ®Google Scholar
• ENGELMANN K, MACK MG, EICHLER K et al.: Interstitial photodynamic laser therapy for liver metastases: first results of a clinical phase I-study. Rofo. (2003) 175:682-687.
   PubMedGoogle Scholar
• BEN-HUR E: Basic photobiology and mechanisms of action of phthalocyanines. In: Photodynamic Therapy: Basic Principles and Clinical Applications. Marcel Dekker Publisher, New York, USA (1992):63-77.
   Google Scholar
• GERBER-LESZCZYSZYN H, ZIOLKOWSKI P, MARSZALIK P: Photodynamic therapy of head and neck tumours and non-tumour like disorders. Otolaryngol. Pol. (2004) 58:339-343.
   PubMedGoogle Scholar
• GILABERTE Y, PEREBOOM D, CARAPETO FJ, ALDA JO: Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin DC. Photodermatol. Photoimmunol. Photomed. (1997) 13:43-49.
   PubMed Web of Science ®Google Scholar
• KUBIN A, WIERRANI F, BURNER U, ALTH G, GRUNBERGER W: Hypericin - the facts about a controversial agent. Curr. Pharm. Des. (2005) 11:233-253.
   PubMed Web of Science ®Google Scholar
• REDMOND RW, GAMLIN JN: A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. (1999) 70:391-475.
   PubMed Web of Science ®Google Scholar
• PYTEL A, SCHMELLER N: New aspect of photodynamic diagnosis of bladder tumours: fluorescence cytology. Urology (2002) 59:216-219.
   PubMed Web of Science ®Google Scholar
• D'HALLEWIN MA, DE WITTE PA, WAELKENS E, MERLEVEDE W, BAERT L: Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J. Urol. (2000) 164:349-351.
   PubMed Web of Science ®Google Scholar
• D'HALLEWIN MA, BEZDETNAYA L, GUILLEMIN F: Fluorescence detection of bladder cancer: a review. Eur. Urol. (2002) 42:417-425.
   PubMed Web of Science ®Google Scholar
• OLIVO M, LAU W, MANIVASAGER V, TAN PH, SOO KC, CHENG C: Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. Int. J. Oncol. (2003) 23:983-990.
   PubMed Web of Science ®Google Scholar
• ALECU M, URSACIUC C, HALALAU F et al.: Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res. (1998) 18:4651-4654.
   PubMed Web of Science ®Google Scholar
• WILSON BD, BERNSTEIN Z, SOMMER C et al.: Photodynamic therapy for Kaposis-sarcoma using Photofrin and tin ethyl-etiopurpurin (SnET2). J. Invest. Dermatol. (1995) 104:693-698.
   Google Scholar
• KOUDINOVA NV, PINTHUS JH, BRANDIS A et al.: Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int. J. Cancer (2003) 104:782-789.
   PubMed Web of Science ®Google Scholar
• HAJRI A, WACK S, MEYER C et al.: In vitro and in vivo efficacy of Photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem. Photobiol. (2002) 75:140-148.
   PubMed Web of Science ®Google Scholar
• BELLNIER DA, GRECO WR, NAVA H, LOEWEN GM, OSEROFF AR, DOUGHERTY TJ: Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. CancerChemother. Pharmacol. (2006) 57:40-45
   Web of Science ®Google Scholar
• KARRER S, ABELS C, SZEIMIES RM et al.: Topical application of a first porphycene dye for photodynamic Therapy penetration studies in human perilesional skin and basal cellcarcinoma. Arch. Dermatol. Res. (1997) 289:132-137.
   PubMed Web of Science ®Google Scholar
• KABUTO M, KUBOTA T, KOBAYASHI H et al.: Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro. No To Shinkei. (1995) 47:969-973.
   PubMedGoogle Scholar
• BAUMLER W, ABELS C, KARRER S et al.: Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br. J. Cancer (1999) 80: 360-363.
   PubMed Web of Science ®Google Scholar
• WILSON BC, JEEVES WP, LOWE DM: In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues. Photochem. Photobiol. (1985) 42:153-162.
   PubMed Web of Science ®Google Scholar
• LIGGETT PE, LAVAQUE AJ, CHAUDHRY NA, JABLON EP, QUIROZ-MERCADO H: Preliminary results of combined simultaneous transpupillary thermotherapy and ICG-based photodynamic therapy for choroidal melanoma. Ophthalmic Surg. Lasers Imaging (2005) 36:463-470.
   PubMed Web of Science ®Google Scholar
• CRESCENZI E, VARRIALE L, IOVINO M, CHIAVIELLO A, VENEZIANI BM, Palumbo G: Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol. Cancer Ther. (2004) 3:537-544.
   PubMed Web of Science ®Google Scholar
• TSENG WW, SAXTON RE, DEGANUTTI A, LIU CD: Infrared laser activation of indocyanine green inhibits growth in human pancreatic cancer. Pancreas (2003) 27:42-45.
   Google Scholar
• BAUMLER W, ABELS C, KARRER S: Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br. J. Cancer (1999) 80:360-363.
   PubMed Web of Science ®Google Scholar
• GOMES AJ, LUNARDI LO, MARCHETTI JM, LUNARDI CN, TEDESCO AC: Indocyanine green nanoparticles useful for photomedicine. Photomedicine and Laser Surgery (2006) 24:514-521.
   PubMed Web of Science ®Google Scholar
• VANTIEGHEM A, ASSEFA Z, VANDENABEELE P et al.: Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett. (1998) 440:19-24.
   PubMed Web of Science ®Google Scholar
• ZHUANG S, LYNCH MC, KOCHEVAR IE: Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Exp. Cell Res. (1999) 250:203-212.
   PubMed Web of Science ®Google Scholar
• WYLD L, REED MW: BROWN NJ: Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br. J. Cancer (200l) 84:1384-1386.
   PubMed Web of Science ®Google Scholar
• ALI SM, OLIVO M: Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells, Int. J. Oncol. (2002) 21:531-540.
   PubMed Web of Science ®Google Scholar
• FERRARIO A, FISHER AM, RUCKER N, GOMER CJ: Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. (2005) 65:9473-9478.
   PubMed Web of Science ®Google Scholar
• SACZKO J, KULBACKA J, CHWILKOWSKA A et al.: The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem. Cytobiol. (2004) 43:129-132.
   Web of Science ®Google Scholar
• IGARASHI A, KONNO H, TANAKA T et al.: Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol. Lett. (2003) 145:133-141.
   PubMed Web of Science ®Google Scholar
• HAJRI A, WACK S, MEYER C et al.: In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells, Photochem. Photobiol. (2002) 75:140-148.
   PubMed Web of Science ®Google Scholar
• NOODT B, BERG T, STOKKE T, PENG Q, NESLAND JM: Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br. J. Cancer (1999) 79:72-81.
   PubMed Web of Science ®Google Scholar
• FISHER M, DANENBERG K, BANERJEE D, BERTINO JR, DANENBERG P, GOMER CJ: Increased photosensitivity in HL60 cells expressing wild-type p53. Photochem. Photobiol. (1997) 66:265-270.
   PubMed Web of Science ®Google Scholar
• TAJIRI H, SHINOMIYA N, HAYAKAWA A, MATSUMOTO Y, YOSHIDA S: Photodynamic therapy-induced rapid cell death by apoptosis in human pancreatic carcinoma transplanted-into nude mice, J. Clin. Biochem. Nutr. (l996) 21:29-37.
   Web of Science ®Google Scholar
• HE XY, SIKES RA, THOMSEN S, CHUNG LW, JACQUES SL: Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol. (1994) 59:468-473.
   PubMed Web of Science ®Google Scholar
• DAS H, KOIZUMI T, SUGIMOTO T et al.: Induction of apoptosis and manganese superoxide dismutase gene by photodynamic therapy in cervical carcinoma celI lines. Int. J. Clin. Oncol. (2000) 5:97-103.
   Web of Science ®Google Scholar
• MARCHAL S, FADLOUN A, MAUGAIN E, D'HALLEWIN MA, GUILLEMIN F, BEZDETNAYA L: Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem. Pharmacol. (2005) 69:1167-1176.
   PubMed Web of Science ®Google Scholar
• TEITEN MH, MARCHAL S, D'HALLEWIN MA, GUILLEMIN F, BEZDETNAYA L: Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells. Photochem. Photobiol. (2003) 78:9-14.
   PubMed Web of Science ®Google Scholar
• LILGE L, PORTNOY M, WILSON BC Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br J. Cancer. (2000) 83:1110-1117.
   PubMed Web of Science ®Google Scholar
• CHEN JY, MAK NK, WEN JM et al.: A comparison of the photodynamic effects of temoporfin (mTHPC) and MC540 00 leukemic cells: efficacy and apoptosis. Photochem. Photobiol. (1998) 68:545-554.
   PubMed Web of Science ®Google Scholar
• GREBENOVA D, KUZELOVA K, SMETANA K et al.:Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by S-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells, J. Photochem. Photobiol. B. (2003) 69:71-85.
   PubMed Web of Science ®Google Scholar
• XIANG W, WEINGANDT H, LIESSMANN F et al.: Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in cul ture, Photochem. Photobiol. (2001) 74:617-623;
   PubMed Web of Science ®Google Scholar
• NOODT BB, BERG K, STOKKE T, PENG Q, NESLAND JM: Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br. J. Cancer (1996) 74:2-29.
   Google Scholar
• WEBBER J, LUO Y, CRILLY R, FROMM D, KESSEL D: An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J. Photochem. Photobiol. B. (l996) 35:09-211.
   Google Scholar
• ALMEIDA RD, MANADAS BJ, CARVALHO AP, DUARTE CB: Intracellular signalling mechanisms in photodynamic therapy Biochimi. Biophys. Acta (2004) 1704:59-86.
   PubMed Web of Science ®Google Scholar
• CASTANO AP, MROZ P, HAMBLIN MR: Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer (2006) 6:35-645.
   Web of Science ®Google Scholar
• CHANG L, KARIN M: Mammalian MAP kinase signalling cascades. Nature (2001) 410:37-40.
   PubMed Web of Science ®Google Scholar
• TONG Z, SINGH G, RAINBOW AJ: Sustained activation of the extracellular signal regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy, Cancer Res. (2002) 62:5528-5535.
   PubMed Web of Science ®Google Scholar
• TONG Z, SINGH G, VALERIE K, RAINBOW AJ: Activation of the stress-activated JNK and p38 MAPK kinases in human cells by Photofrin-mediated photodynamic therapy. J. Photochem. Photobiol. B. (2003) 71:7-85.
   Google Scholar
• SOLBAN N, SELBO PK, SINHA AK, CHANG SK, HASAN T: Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res. (2006) 66:633-5640.
   Google Scholar
• HENDRICKX N, DEWAELE M, BUYTAERT E et al.: Targeted inhibition of p38α MAPK suppresses tumor-associated endothelialcell migration in response to hypericin-based photodynamic therapy. Biochem. Biophys. Res. Commun. (2005) 337:928-935.
   PubMed Web of Science ®Google Scholar
• HENDRICKX N, VOLANTI C, MOENS U et al.: Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. (2003) 278:52231-52239.
   PubMed Web of Science ®Google Scholar
• LUNA MC, WONG S, GOMER CJ: Photodynamic therapy mediated induction of early response genes, Cancer Res. (1994) 54:1374-1380.
   PubMed Web of Science ®Google Scholar
• KICK G, MESSER G, PLEWIG G, KIND P, GOETZ AE: Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br. J. Cancer (l996) 74:30- 36.
   Google Scholar
• KICK G, MESSER G, GOETZ A, PLEWIG G, KIND P: Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding.Cancer Res. (1995) 55:373-2379.
   Google Scholar
• RYTER SW, GOMER CJ: Nuclear factor kappa B binding activity in mouse L1210 cells following photofrinII-mediated photosensitization. Photochem. Photobiol. (1993) 58:753-756.
   PubMed Web of Science ®Google Scholar
• VOLANTI C, HENDRICKX N, VAN LINT J, MATROULE JY, AGOSTINIS P, PIETTE J: Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene (2005) 24:2981-2991.
   PubMed Web of Science ®Google Scholar
• VOLANTI C, GLOIRE G, VANDERPLASSCHEN A, JACOBS N, HABRAKEN Y, PIETTE J: Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene (2004) 23:8649-8658.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, CARTHY CM, JIANG H et al.: Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 95:26-262.
   Google Scholar
• AHMAD N, GUPTA S, MUKHTAR H: Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Oncogene (1999) 18:1891-896.
   PubMed Web of Science ®Google Scholar
• COLUSSI VC, FEYES DK, MULVIHILL JW et al.: Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem. Photobiol. (1999) 69:236-241.
   PubMed Web of Science ®Google Scholar
• CRESCENZI E, CHIAVIELLO A, CANTI G, REDDI E, VENEZIANI BM, PALUMBO G: Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). Mol. Cancer Ther. (2006) 53:776-785.
   Google Scholar
• LEE HB, HO AS, TEO SH: p53 Status does not affect photodynamic cell killing induced by hypericin. Cancer Chemother. Pharmacol. (2006) 58:1-98.
   PubMed Web of Science ®Google Scholar
• CURRY PM, LEVY JG: Stress protein expression in murine tumor ells following photodynatnic therapy with benzoporphyrin derivative. Photochem. Photobiol. (l993) 58:374-379.
   PubMed Web of Science ®Google Scholar
• MITRA S, GOREN EM, FRELINGER JG, FOSTER TH: Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo. Photochem. Photobiol. (2003) 78:615-622.
   PubMed Web of Science ®Google Scholar
• NONAKA M, IKEDA H, INOKUCHI T: Inhibitory effect of heat shock protein 70 on apoptosis induced by photodynamic therapy in vitro. Photochem. Photobiol. (2004) 79:94-98.
   PubMed Web of Science ®Google Scholar
• KONAN YN, BERTON M, GURNY R, ALLEMANN E: Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles Eur. J. Pharm. Sci. (2003) 18:241-249.
   PubMed Web of Science ®Google Scholar
• KONAN YN, CHEVALLIER J, GURNY R, ALLEMANN E: Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity: Photochem. Photobiol. (2003) 77:638-644.
   PubMed Web of Science ®Google Scholar
• RICCI-JUNIOR E, MARCHETTI JM: Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. (2006) 310:187-195.
   PubMed Web of Science ®Google Scholar
• GOMES AJ, LUNARDI LO, MARCHETTI JM, LUNARDI CN, TEDESCO AC: Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitiser useful for PDT treatment. Drug Deliv. (2005) 12:159-164.
   PubMed Web of Science ®Google Scholar
• WIEDER ME, HONE DC, COOK MJ, HANDSLEY MM, GAVRILOVIC J, RUSSELL DA: Intracellular photodynamic therapy with photosensitiser-nanoparticle conjugates: cancer therapy using a Trojan horse. Photochem. Photobiol. Sci. (2006) 5:727-734.
   Google Scholar
• ROY I, OHULCHANSKYY TY, PUDAVAR HE et al.: Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am. Chem. Soc. (2003) 125:7860-7865.
   PubMed Web of Science ®Google Scholar
• YAN F, KOPELMAN R: The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties. Photochem. Photobiol. (2003) 78:587-591.
   PubMed Web of Science ®Google Scholar
• CINTEZA LO, OHULCHANSKYY TY, SAHOO Y et al.: Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol. Pharm. (2006) 3:415-423.
   PubMed Web of Science ®Google Scholar
• OSEROFF AR, OHUOHA D, HASAN T: Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc. Natl. Acad. Sci. USA (1986) 83:8744-8748.
   PubMed Web of Science ®Google Scholar
• DUSKA LR, HAMBLIN MR, MILLER JL, HASAN T: Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J. Natl. Cancer Inst. (1999) 191:1557-1563.
   Google Scholar
• HAMBLIN MR, MILLER JL, HASAN T: Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res. (1996) 56:5205-5210.
   PubMed Web of Science ®Google Scholar
• FRIEDRICH SW, LIN SC, STOLL BR, BAXTER LT, MUNN LL, JAIN RK: Antibody-directed effector cell therapy of tumors: analysis and optimization. Neoplasia (2002) 4:449-463.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER R, SCHMITT F, FROCHOT C et al.: Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitisers for selective photodynamic therapy. Bioorg. Med. Chem. (2005) 13:2799-2808.
   PubMed Web of Science ®Google Scholar
• PALUMBO G et al.: unpublished results (2006).
   Google Scholar
• RHODES LE, TSOUKAS MM, ANDERSON RR, KOLLIAS N: Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J. Invest. Dermatol. (1997) 108:87-91.
   PubMed Web of Science ®Google Scholar
• LOPEZ RF, BENTLEY MV, DELGADO-CHARRO MB et al.: Related Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem. Photobiol. (2003) 77:304-308.
   PubMed Web of Science ®Google Scholar
• TACHIBANA K, TACHIBANA S: The use of ultrasound for drug delivery. Echocardiography (2001) 18:323-328.
   PubMed Web of Science ®Google Scholar
• FERRARIO A, FISHER AM, RUCKER N, GOMER CJ: Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. (2005) 65:9473-9478.
   PubMed Web of Science ®Google Scholar
• GOLAB J, WILCZYNSKI G, ZAGOZDZON R et al.: Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br. J.Cancer (2000) 82:1485-1491.
   PubMed Web of Science ®Google Scholar
• CANTI G, NICOLIN A, CUBEDDU R, TARONI P, BANDIERAMONTE G, VALENTINI G. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. (1998) 125:39-44.
   PubMed Web of Science ®Google Scholar
• SKYRME RJ, FRENCH AJ, DATTA SN, ALLMAN R, MASON MD, MATTHEWS PN: A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int. (2005) 95:1206-1210.
   PubMed Web of Science ®Google Scholar
• UEHARA M, INOKUCHI T, IKEDA H: Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin. J. Oral. Maxillofac. Surg. (2006) 64:390-396.
   PubMed Web of Science ®Google Scholar
• NONAKA M, IKEDA H, INOKUCHI T: Effect of combined photodynamic and chemotherapeutic treatment on lymphoma cells in vitro. Cancer Lett. (2002) 184:171-178.
   PubMed Web of Science ®Google Scholar
• LOTTNER C, KNUECHEL R, BERNHARDT G, BRUNNER H: Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells. Cancer Lett. (2004) 215:167-177.
   PubMed Web of Science ®Google Scholar
• DEL CARMEN MG, RIZVI I, CHANG Y et al.: Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J. Natl. Cancer Inst. (2005) 97:1516-1524.
   PubMed Web of Science ®Google Scholar
• LOU PJ, JAGER HR, JONES L, THEODOSSY T, BOWN SG, HOPPER C: Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br. J. Cancer. (2004) 91:441-446.
   PubMed Web of Science ®Google Scholar